Metoprolol succinate and hydrochlorothiazide tablet

# Disclaimer
WikiDoc MAKES NO GUARANTEE OF VALIDITY. WikiDoc is not a professional health care provider, nor is it a suitable replacement for a licensed healthcare provider.  WikiDoc is intended to be an educational tool, not a tool for any form of healthcare delivery.  The educational content on WikiDoc drug pages is based upon the FDA package insert, National Library of Medicine content and practice guidelines / consensus statements.  WikiDoc does not promote the administration of any medication or device that is not consistent with its labeling. Please read our full disclaimer here.

# Black Box Warning

# Overview
Metoprolol succinate and hydrochlorothiazide tablet is {{{aOrAn}}} {{{drugClass}}} that is FDA approved for the {{{indicationType}}} of {{{indication}}}. There is a Black Box Warning for this drug as shown here.  Common adverse reactions include {{{adverseReactions}}}.

# Adult Indications and Dosage

## FDA-Labeled Indications and Dosage (Adult)
There is limited information regarding Metoprolol succinate and hydrochlorothiazide tablet FDA-Labeled Indications and Dosage (Adult) in the drug label.

## Off-Label Use and Dosage (Adult)

### Guideline-Supported Use
There is limited information regarding Off-Label Guideline-Supported Use of Metoprolol succinate and hydrochlorothiazide tablet in adult patients.

### NonGuideline-Supported Use
There is limited information regarding Off-Label NonGuideline-Supported Use of Metoprolol succinate and hydrochlorothiazide tablet in adult patients.

# Pediatric Indications and Dosage

## FDA-Labeled Indications and Dosage (Pediatric)
There is limited information regarding Metoprolol succinate and hydrochlorothiazide tablet FDA-Labeled Indications and Dosage (Pediatric) in the drug label.

## Off-Label Use and Dosage (Pediatric)

### Guideline-Supported Use
There is limited information regarding Off-Label Guideline-Supported Use of Metoprolol succinate and hydrochlorothiazide tablet in pediatric patients.

### NonGuideline-Supported Use
There is limited information regarding Off-Label NonGuideline-Supported Use of Metoprolol succinate and hydrochlorothiazide tablet in pediatric patients.

# Contraindications
There is limited information regarding Metoprolol succinate and hydrochlorothiazide tablet Contraindications in the drug label.

# Warnings
There is limited information regarding Metoprolol succinate and hydrochlorothiazide tablet Warnings' in the drug label.

# Adverse Reactions

## Clinical Trials Experience
There is limited information regarding Metoprolol succinate and hydrochlorothiazide tablet Clinical Trials Experience in the drug label.

## Postmarketing Experience
There is limited information regarding Metoprolol succinate and hydrochlorothiazide tablet Postmarketing Experience in the drug label.

# Drug Interactions
There is limited information regarding Metoprolol succinate and hydrochlorothiazide tablet Drug Interactions in the drug label.

# Use in Specific Populations

### Pregnancy
Pregnancy Category (FDA): 
There is no FDA guidance on usage of Metoprolol succinate and hydrochlorothiazide tablet in women who are pregnant.
Pregnancy Category (AUS): 
There is no Australian Drug Evaluation Committee (ADEC) guidance on usage of Metoprolol succinate and hydrochlorothiazide tablet in women who are pregnant.

### Labor and Delivery
There is no FDA guidance on use of Metoprolol succinate and hydrochlorothiazide tablet during labor and delivery.

### Nursing Mothers
There is no FDA guidance on the use of Metoprolol succinate and hydrochlorothiazide tablet in women who are nursing.

### Pediatric Use
There is no FDA guidance on the use of Metoprolol succinate and hydrochlorothiazide tablet in pediatric settings.

### Geriatic Use
There is no FDA guidance on the use of Metoprolol succinate and hydrochlorothiazide tablet in geriatric settings.

### Gender
There is no FDA guidance on the use of Metoprolol succinate and hydrochlorothiazide tablet with respect to specific gender populations.

### Race
There is no FDA guidance on the use of Metoprolol succinate and hydrochlorothiazide tablet with respect to specific racial populations.

### Renal Impairment
There is no FDA guidance on the use of Metoprolol succinate and hydrochlorothiazide tablet in patients with renal impairment.

### Hepatic Impairment
There is no FDA guidance on the use of Metoprolol succinate and hydrochlorothiazide tablet in patients with hepatic impairment.

### Females of Reproductive Potential and Males
There is no FDA guidance on the use of Metoprolol succinate and hydrochlorothiazide tablet in women of reproductive potentials and males.

### Immunocompromised Patients
There is no FDA guidance one the use of Metoprolol succinate and hydrochlorothiazide tablet in patients who are immunocompromised.

# Administration and Monitoring

### Administration
There is limited information regarding Metoprolol succinate and hydrochlorothiazide tablet Administration in the drug label.

### Monitoring
There is limited information regarding Metoprolol succinate and hydrochlorothiazide tablet Monitoring in the drug label.

# IV Compatibility
There is limited information regarding the compatibility of Metoprolol succinate and hydrochlorothiazide tablet and IV administrations.

# Overdosage
There is limited information regarding Metoprolol succinate and hydrochlorothiazide tablet overdosage.  If you suspect drug poisoning or overdose, please contact the National Poison Help hotline (1-800-222-1222) immediately.

# Pharmacology
There is limited information regarding Metoprolol succinate and hydrochlorothiazide tablet Pharmacology in the drug label.

## Mechanism of Action
There is limited information regarding Metoprolol succinate and hydrochlorothiazide tablet Mechanism of Action in the drug label.

## Structure
There is limited information regarding Metoprolol succinate and hydrochlorothiazide tablet Structure in the drug label.

## Pharmacodynamics
There is limited information regarding Metoprolol succinate and hydrochlorothiazide tablet Pharmacodynamics in the drug label.

## Pharmacokinetics
There is limited information regarding Metoprolol succinate and hydrochlorothiazide tablet Pharmacokinetics in the drug label.

## Nonclinical Toxicology
There is limited information regarding Metoprolol succinate and hydrochlorothiazide tablet Nonclinical Toxicology in the drug label.

# Clinical Studies
There is limited information regarding Metoprolol succinate and hydrochlorothiazide tablet Clinical Studies in the drug label.

# How Supplied
There is limited information regarding Metoprolol succinate and hydrochlorothiazide tablet How Supplied in the drug label.

## Storage
There is limited information regarding Metoprolol succinate and hydrochlorothiazide tablet Storage in the drug label.

# Images

## Drug Images

## Package and Label Display Panel

# Patient Counseling Information
There is limited information regarding Metoprolol succinate and hydrochlorothiazide tablet Patient Counseling Information in the drug label.

# Precautions with Alcohol
Alcohol-Metoprolol succinate and hydrochlorothiazide tablet interaction has not been established. Talk to your doctor about the effects of taking alcohol with this medication.

# Brand Names
There is limited information regarding Metoprolol succinate and hydrochlorothiazide tablet Brand Names in the drug label.

# Look-Alike Drug Names
There is limited information regarding Metoprolol succinate and hydrochlorothiazide tablet Look-Alike Drug Names in the drug label.

# Drug Shortage Status

# Price